Skip to main content

Market Overview

Evogene Ltd. (NYSE: EVGN)

3.65 -0.10 (-2.67%)

Analyst Ratings

DateResearch FirmActionCurrentPT
12/01/20Cantor FitzgeraldInitiates Coverage OnOverweight9.0
11/12/14Credit SuisseMaintainsOutperform22.0
12/17/13Deutsche BankInitiates Coverage OnBuy22.0
12/16/13Credit SuisseInitiates Coverage OnOutperform25.0

Data powered by Benzinga Pro Calendars - Start your FREE TRIAL today!

Sign up to receive Benzinga's Daily Ratings Newsletter